Botulinum neurotoxin type G

BE0009357ProteinClostridium botulinumbotG

Botulinum neurotoxin type G Botulinum toxin causes flaccid paralysis by inhibiting neurotransmitter (acetylcholine) release from the presynaptic membranes of nerve terminals of the eukaryotic host skeletal and autonomic nervous system, with frequent heart or respiratory... It is acted on by 1 drug in DrugBank.

Gene name
botG
UniProtKB entry
Q60393Swiss-Prot
Cellular location
Secreted
Residues / weight
1,297 residues
Also known as
3.4.24.69 · BoNT/G · Bontoxilysin-G

Resolves to

Protein
UniProtQ60393UniProt nameBXG_CLOBO
Structure
PDB1ZB7PDB2VXRPDB3MPP
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
6GO termsFunction, process and component, as structured annotations
Sign in
4Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Botulinum neurotoxin type G, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In